Core Viewpoint - *ST SiHuan (000518.SZ) expects a net profit attributable to shareholders of the listed company to be between -40 million to -30 million yuan for the year 2025, with a net profit after deducting non-recurring gains and losses projected to be between -46 million to -33 million yuan [1] Group 1: Financial Performance - The company's revenue growth is primarily attributed to a significant increase in seedling sales from its wholly-owned subsidiary, Jiangsu Chenwei Ecological Park Technology Co., Ltd. [1] - The reduction in net loss year-on-year is mainly due to decreased asset impairment losses and operating expenses, as well as improved cost control measures by its controlling subsidiary, Beijing SiHuan Biological Pharmaceutical Co., Ltd. [1]
*ST四环(000518.SZ):2025年预亏3000万元至4000万元